Unresectable Advanced Cancer
1 clinical trials · Condition
◉ Watch Unresectable Advanced Cancer
| Record | Firm | Date |
|---|---|---|
| A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer (NCT02640365) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2015-11-18 |
Track Unresectable Advanced Cancer automatically
Every clearance here is in the API, with alerts when new ones post.